Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Berenberg lifts target price on Discoverie following H1 update

(Sharecast News) - Analysts at Berenberg lifted their target price for DiscoverIE from 1,050p to 1,100p on Thursday, citing sustained organic momentum, a strengthening order book and earnings running ahead of expectations. Berenberg, which reiterated its 'buy' rating on the stock, argued that the Discoverie's quality‑compounder model continues to offer upside and said the firm's H1 trading update confirmed a clear acceleration in organic growth, with the group expecting 10% year‑on‑year organic growth for the half.

Organic orders rose 22%, marking more than a year of consecutive order book build and underpinning future delivery. Berenberg also raised its adjusted earnings per share forecasts by 2% to 3% across the forecast period.

Momentum was broad‑based, led by Discoverie's magnetics and controls unit, which grew 13% organically, while sensing and connectivity was now positioned to accelerate as supply lead times normalise and tougher comparators fall away. Orders increased 25% in M&C and 18% in S&C, producing a book‑to‑bill ratio of 1.12.

Overall sales rose 13% at constant currency, supported by recent acquisitions, while net debt-to-underkying earnings stood at 1.6x at the end of September, rising to around 1.8x post‑acquisition, which Berenberg said still leaves roughly £35m of short‑term M&A capacity.

Berenberg added that DiscoverIE's long‑term compounding potential remains underappreciated, with management's 17% FY30 EBIT margin target and the benefits of the 3Gmetalworx deal not yet reflected in forecasts, offering a supportive backdrop for shareholder returns. Regulatory approval for the firm's acquisition of 3Gmetalworx was said to be progressing, with completion expected shortly

Reporting by Iain Gilbert at Sharecast.com

Share this article

Related Sharecast Articles

Berenberg raises target price on Persimmon, keeps 'hold' rating
(Sharecast News) - Analysts at Berenberg raised their target price on housebuilder Persimmon from 1,150p to 1,240p on Friday after lifting their 2026-27 earnings per share estimates by an average of 2% following the group's third-quarter trading update.
Wise H1 profits climb as customer base tops 16m
(Sharecast News) - Global fintech group Wise reported a jump in first-half revenue and profits on Friday, putting the recently dual-listed firm on track to hit the upper end of its full-year growth targets.
GSK wins positive CHMP opinion for Bexsero meningitis B booster
(Sharecast News) - Pharmaceutical giant GSK said on Friday that the European Medicines Agency's Committee for Medicinal Products for Human Use had issued a positive opinion recommending a label update for its Bexsero meningitis B vaccine.
Major Microsoft outage hits hospitals, businesses and financial markets worldwide
(Sharecast News) - A global Microsoft outage has disrupted businesses, government agencies and other organisations worldwide, leaving users without a slew of vital services in what is one of the group's most prolonged service disruptions in history.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.